Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Ivana
Ivana Buricova, Usti Nad Labem CZ
| Patent application number | Description | Published |
|---|---|---|
| 20090082601 | METHOD OF PREPARING DICHLOROPANOLS FROM GLYCERINE - A method of highly selective catalytic hydrochlorination of glycerine and/or monochloropropanediols to the dichloropropanol products 1,3-dichloro-2-propanol and 2,3-dichloro-1-propanol, carried out in at least one continuous reaction zone at reaction temperatures in the range of 70-140° C. and with continuous removing of the water of reaction, the liquid feed containing at least 50% by weight of glycerine and/or monochloropropanediols. The method can be carried out in a continuously operating one-step circulation reactor or a cascade of continuous flow reactors of the liquid-gas type. | 03-26-2009 |
Ivana Celic, Baltimore, MD US
| Patent application number | Description | Published |
|---|---|---|
| 20090068695 | Sir2 products and activities - A novel compound, 2′/3′-O-acetyl-ADP-ribose, is provided. The compound is a mixture of the 2′ and 3′ regioisomers of O-acetyl-ADP ribose, and is formed nonenzymatically from 2′-O-acetyl-ADP-ribose, which is the newly discovered product of the reaction of Sir2 enzymes with acetylated peptides and NAD | 03-12-2009 |
Ivana Crocci De Souza, Vila Olimpia BR
| Patent application number | Description | Published |
|---|---|---|
| 20100070341 | METHOD FOR THE FOLLOW-UP AND BEHAVIOR ASSESSMENT OF PARKS OF ATM TERMINALS BY MEANS OF STATISTICAL ANALYSES AND/OR GENERATION OF GRAPHICS OF UPDATED INDICATORS - The “METHOD FOR THE FOLLOW-UP AND BEHAVIOR ASSESSMENT OF PARKS OF ATM TERMINALS BY MEANS OF STATISTICAL ANALYSES AND/OR GENERATION OF GRAPHICS OF UPDATED INDICATORS” is related, more specifically, to a method prominently developed so that the outsourcing clients, owners of networks managed by other companies, such as banks and other companies which utilize ATM terminals, are enabled to perform a follow-up and assessment of the behavior of their parks of ATM terminals by means of statistical analyses and/or the generation of graphics of updated indicators within the shortest period of time possible, thus providing conditions for the making of strategic and operational decisions based on information supplied on-line. | 03-18-2010 |
Ivana Dodig, Zagreb HR
| Patent application number | Description | Published |
|---|---|---|
| 20110212531 | Mass Spectrometry-Based Protein Identification Method - A method of detection of amino acid sequences and/or identification of proteins and peptides is based on derivatization of peptides or proteins using compounds comprising two or more sulfonyl groups, and subsequent analysis of the derivatized analytes using a mass spectrometer in its negative mode of operation. | 09-01-2011 |
Ivana Durickovic, Metz FR
| Patent application number | Description | Published |
|---|---|---|
| 20110222055 | DETERMINATION OF THE SALT CONCENTRATION OF AN AQUEOUS SOLUTION - A method of determining the concentration of a salt that may be present in a substance containing at least some water, comprising the following steps: a) recording the Raman spectrum of photons scattered by the substance in the wave number range 2500 cm | 09-15-2011 |
| 20110228265 | PROCESS FOR THE DETERMINATION OF THE SOLID/LIQUID PHASE - A method of determining the solid/liquid phase of an aqueous solution, characterized in that it comprises the following steps: a) subjecting said aqueous solution to a beam of photons; b) recording the Raman spectrum of the photons scattered by said solution in the wave number range between 2500 cm | 09-22-2011 |
Ivana Girdzijauskas, Kista SE
| Patent application number | Description | Published |
|---|---|---|
| 20110285813 | Depth and Video Co-Processing - Co-processing of a video frame ( | 11-24-2011 |
Ivana Hrbud, Lafayette, IN US
| Patent application number | Description | Published |
|---|---|---|
| 20100058734 | METHOD OF ENHANCING MICROTHRUSTER PERFORMANCE - Coaxial micronozzle designs are presented. Initial coaxial micronozzle designs utilizing center-body geometries to better exploit pressure thrust show a potential threefold increase in specific impulse under vacuum and near vacuum conditions. | 03-11-2010 |
Ivana Miletto, Torino IT
| Patent application number | Description | Published |
|---|---|---|
| 20110201784 | FUNCTIONALIZED CYANINE HAVING A SILANE LINKER ARM, A METHOD OF PREPARING THEREOF AND USES THEREOF - A silane-modified cyanine of Formula (I) includes the valence tautomers thereof: wherein R | 08-18-2011 |
Ivana Palej, Zagreb HR
| Patent application number | Description | Published |
|---|---|---|
| 20080249033 | Carbamate Linked Macrolides Useful For The Treatment Of Microbial Infections - The present invention relates to 14- or 15-membered macrolides substituted at the 4″ position of formula (I) | 10-09-2008 |
| 20080255060 | Ester Linked Macrolides Useful For The Treatment of Microbial Infections - The present invention relates to 14- or 15-membered macrolides substituted at the 4″ position of formula (I) | 10-16-2008 |
| 20090170791 | MACROLONES - A compound of formula (I) | 07-02-2009 |
Ivana Silva Lula, Belo Horizente Mg BR
| Patent application number | Description | Published |
|---|---|---|
| 20100144624 | PROCESS FOR THE PREPARATION OF COMPOSITIONS OF AT1 RECEPTOR ANTAGONIST AND ANGIOTENSIN-(1-7) - We describe preparation of compounds of an AT1 receptor antagonist(s) and Angiotensin (1-7), for example, Angiotensin-(1-7) losartanate and analogues thereof, and/or mixtures of these systems, pharmaceutical compositions thereof and use of their derivative products. Cyclodextrins and derivatives thereof may be used for the micro-encapsulation of compounds, for example, Angiotensin (1-7) losartanate, liposomes and biodegradable polymers and/or mixtures of these systems and/or derivative products for the obtainment of nano- or microparticles as controlled or sustained release devices of Ang-(1-7) losartanate and analogues and/or mixtures thereof. The compounds may be used as agents for treating or preventing hypertension, cardiovascular diseases, heart hypertrophy, heart failure, coronary diseases, such as angina pectoris, endothelial disorder or endothelial lesions, as a consequence, for example, of atherosclerosis processes or in association with diabetes mellitus. They may also be used in the study and therapy of cardiovascular, renal, reproductive, dermatological, neoplastic, blood and cerebral diseases, and when formulated in controlled release systems, encapsulated or not in cyclodextrins, for use in stent, with a view to modulate the growth of the neointima after catheterization procedures. | 06-10-2010 |
Ivana Silva Lula, Belo Horizonte-Mg BR
| Patent application number | Description | Published |
|---|---|---|
| 20080312129 | Use of Mas G-Protein-Coupled Receptor Agonists and Antagonists, as Apoptotic-Activity Modulators for Study, Prevention and Treatment of Diseases - The present invention is characterized by the use of Mas G-protein-coupled receptor agonists and antagonists as apoptotic activity modulators for study, prevention and treatment of diseases. It is further characterized by the use of Mas G-protein-coupled receptor agonist and antagonists for modulation of the apoptotic activity involving alterations in the activity of the protein kinase B/Akt. Another characteristic of the invention is the use of Mas G-protein-coupled receptor agonists and antagonists, including the Ang-(1-7) peptide and its analogues, agonists and antagonists, either peptidic or non-peptidic, as modulators of apoptotic activity for study, prevention and treatment of degenerative diseases of organs and systems, as an auxiliary measure for organs transplantation, treatment with embryonic, non-embryonic stem cells, re-implantation of organs and tissues and other treatments that need temporary or chronic reduction of the apoptotic activity, not limitative. The invention further claims the use of Mas G-protein-coupled receptor agonists and antagonists, including the Angiotensin-(1-7) peptide and its analogues, agonists and antagonists, either peptidic or non-peptidic, formulated with pharmaceutically and pharmacologically acceptable excipients or carriers, as modulators of the apoptotic activity. | 12-18-2008 |
Ivana Strahinjic, Reinbek DE
| Patent application number | Description | Published |
|---|---|---|
| 20090311308 | SKINCARE COMPOSITIONS COMPRISING SALICYCLIC ACID - There is disclosed a skincare composition suitable for topical application to the skin. The composition comprises salicylic acid or a salt thereof and hydrolysed milk protein. The composition is useful in the treatment of acne. | 12-17-2009 |
Ivana Türbachova, Berlin DE
| Patent application number | Description | Published |
|---|---|---|
| 20090305234 | Specific DNAS for Epigenetic Characterisation of Cells and Tissues - The present invention provides methods, nucleic acids and molecular markers for the characterization of cells, tissues and heterogeneous mixtures of cells. Specifically, it describes particular genes and genomic regions in which DNA methylation patterns are a consistent and characteristic property of different cell types, states and stages of differentiation. The invention is useful in determining the identity, composition, quality and potency of cells and cell populations. Furthermore, the invention will be useful in monitoring the differentiation of cells. | 12-10-2009 |
| 20110177505 | DNA Methylation Analysis of Regulatory T Cells Through DNA-Methylation Analysis of the TSDR Region of the Gene FOXP3 - The present invention relates to a method, in particular an in vitro method for identifying FoxP3-positive CD25+CD4+ regulatory T cells of a mammal, comprising analyzing the methylation status of at least one CpG position in the FOXP3 gene, in particular its “upstream” regulatory regions, and in particular the promoter and the TSDR region of the gene foxp3, wherein a demethylation to at least 90% of at least one CpG in the sample as analyzed is indicative for a FoxP3-positive CD25 | 07-21-2011 |
Ivana Türbachova, Berlin DE
| Patent application number | Description | Published |
|---|---|---|
| 20090305234 | Specific DNAS for Epigenetic Characterisation of Cells and Tissues - The present invention provides methods, nucleic acids and molecular markers for the characterization of cells, tissues and heterogeneous mixtures of cells. Specifically, it describes particular genes and genomic regions in which DNA methylation patterns are a consistent and characteristic property of different cell types, states and stages of differentiation. The invention is useful in determining the identity, composition, quality and potency of cells and cell populations. Furthermore, the invention will be useful in monitoring the differentiation of cells. | 12-10-2009 |
Ivana Zednickova, Lanskroun CZ
| Patent application number | Description | Published |
|---|---|---|
| 20100025876 | BINDER REMOVAL FROM PARTICULATE BODIES - The present invention relates to a method of manufacturing a porous article, in particular the anode of a valve action material based solid state capacitor, comprising the steps of combining a water soluble polymeric binder and particulate material before pressing the particulate material and the subsequent step of removing the binder form the pressed pellet. Thus, the present invention also relates to a method of removing a water soluble polymeric binder from pressed particulate material and to a composition comprising a water soluble polymeric binder for forming the anode of a valve action material based solid state capacitor. | 02-04-2010 |